US Stock MarketDetailed Quotes

Day One Biopharmaceuticals (DAWN)

Watchlist
  • 21.200
  • +8.420+65.88%
Close Mar 6 16:00 ET
  • 21.150
  • -0.050-0.24%
Pre 05:50 ET
2.19BMarket Cap-20.38P/E (TTM)

Day One Biopharmaceuticals (DAWN) Key Financial Indicators

DAWN Earnings per Share (EPS)

According to the latest financial report of Day One Biopharmaceuticals, the latest earnings per share (TTM) for the company is -0.21. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

DAWN Free Cash Flow (FCF)

Interested in knowing about Day One Biopharmaceuticals's free cash flow? The latest report shows it as -14.15M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

DAWN Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Day One Biopharmaceuticals shows that the company's current ratio is 8.02, indicating healthy liquidity.

Currency: USD

Quarterly

Loading...

DAWN Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Day One Biopharmaceuticals, the quick ratio is 7.73, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

Loading...

DAWN Return on Equity (ROE)

Want to learn more about the financial health of Day One Biopharmaceuticals? The latest ROE figure is -4.77%, indicating that the company has stable profitability.

Currency: USD

Quarterly

Loading...

DAWN Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Day One Biopharmaceuticals, the total asset return on investment (ROA) is -4.17%.

Currency: USD

Quarterly

Loading...

DAWN Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Day One Biopharmaceuticals's latest financial report to see how their gross margin is doing - currently at 88.68%.

Currency: USD

Quarterly

Loading...

DAWN Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Day One Biopharmaceuticals, the net profit margin is -39.61%, which is a good sign for its profitability.

Currency: USD

Quarterly

Loading...

Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the conflict between the US and Iran has continued, with the Strait of Hormuz at a standstill. A surge in oil prices, compounded b Show More